Literature DB >> 21063861

Nocturnal acid breakthrough on proton pump inhibitor therapy: to treat or not to treat.

Philip O Katz1, Robert S Dudnick.   

Abstract

OPINION STATEMENT: Nocturnal acid breakthrough is misunderstood and infrequently requires treatment in everyday practice. There are important subgroups of patients in whom esophageal reflux occurs in the presence of nocturnal acid breakthrough in which treatment may be needed.

Entities:  

Year:  2008        PMID： 21063861     DOI： 10.1007/s11938-008-0004-z

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN： 1092-8472


  20 in total

1.  Helicobacter pylori eradication increases nocturnal acid breakthrough.

Authors:  M A van Herwaarden; M Samsom; A J Smout
Journal:  Aliment Pharmacol Ther       Date:  2000-07       Impact factor: 8.171

2.  Proton pump inhibitors: better acid suppression when taken before a meal than without a meal.

Authors:  J G Hatlebakk; P O Katz; L Camacho-Lobato; D O Castell
Journal:  Aliment Pharmacol Ther       Date:  2000-10       Impact factor: 8.171

3.  Helicobacter pylori infection influences nocturnal gastric acid breakthrough.

Authors:  T Katsube; K Adachi; A Kawamura; K Amano; Y Uchida; M Watanabe; Y Kinoshita
Journal:  Aliment Pharmacol Ther       Date:  2000-08       Impact factor: 8.171

4.  Effect of splitting the dose of esomeprazole on gastric acidity and nocturnal acid breakthrough.

Authors:  J Hammer; B Schmidt
Journal:  Aliment Pharmacol Ther       Date:  2004-05-15       Impact factor: 8.171

5.  Comparison of the effects of immediate-release omeprazole oral suspension, delayed-release lansoprazole capsules and delayed-release esomeprazole capsules on nocturnal gastric acidity after bedtime dosing in patients with night-time GERD symptoms.

Authors:  P O Katz; F K Koch; E D Ballard; R G Bagin; T C Gautille; G C Checani; D L Hogan; V S V Pratha
Journal:  Aliment Pharmacol Ther       Date:  2007-01-15       Impact factor: 8.171

6.  Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls.

Authors:  B Kuo; D O Castell
Journal:  Am J Gastroenterol       Date:  1996-08       Impact factor: 10.864

7.  A comparison of esomeprazole and lansoprazole for control of intragastric pH in patients with symptoms of gastro-oesophageal reflux disease.

Authors:  D A Johnson; T Stacy; M Ryan; T Wootton; J Willis; K Hornbuckle; W Brooks; M Doviak
Journal:  Aliment Pharmacol Ther       Date:  2005-07-15       Impact factor: 8.171

8.  Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors.

Authors:  P L Peghini; P O Katz; N A Bracy; D O Castell
Journal:  Am J Gastroenterol       Date:  1998-05       Impact factor: 10.864

9.  Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus.

Authors:  Hashem B El-Serag; Thomas V Aguirre; Stephanie Davis; Mark Kuebeler; Achyut Bhattacharyya; Richard E Sampliner
Journal:  Am J Gastroenterol       Date:  2004-10       Impact factor: 10.864

10.  Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure.

Authors:  Tina M Ours; W Keith Fackler; Joel E Richter; Michael F Vaezi
Journal:  Am J Gastroenterol       Date:  2003-03       Impact factor: 10.864
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.